Relationship between High Levels of Fasting Blood Glucose and Functional Outcome after Intravenous Thrombolysis in Patients with Ischemic Stroke

doi:10.3969/j.issn.1673-5765.2024.03.007

Abstract

Abstract: Objective To investigate the association between fasting blood glucose and functional outcomes in ischemic stroke patients treated with intravenous thrombolysis.
Methods The study data of patients treated with intravenous thrombolysis in Beijing Tiantan Hospital, Capital Medical University from October 2018 to November 2020 were collected retrospectively. Ischemic stroke patients who received alteplase intravenous thrombolysis within 4.5 h of onset were included, and study data including fasting blood glucose were collected. The study outcome was set as a good functional outcome at discharge (mRS score 0-1). Multivariate logistic regression analysis was used to investigate the association between the fasting blood glucose and functional outcomes.
Results A total of 205 patients were enrolled. The mean age was (63.21±11.67) years. The percentage of male was 153 (74.63%). The admission NIHSS score was 5 (3-9). There were 117 patients (57.07%) who did not have a good functional outcome at discharge and 88 patients (42.93%) who did. Fasting blood glucose levels in patients with good functional outcomes were lower than those in patients with poor functional outcomes [5.10 (4.46-7.06) mmol/L vs. 6.33 (5.09-7.79) mmol/L, P=0.001]. Multivariate logistic regression analysis showed that after adjusting for age, gender, and NIHSS score, there was a correlation between fasting blood glucose level and the outcome of receiving intravenous thrombolysis (OR 0.876, 95%CI 0.774-0.991, P=0.035). After adjusting for age, sex, NIHSS score and mechanical thrombectomy, the association was not statistically significant (OR 0.891, 95%CI 0.791-1.004, P=0.058).
Conclusions In ischemic stroke patients undergoing intravenous thrombolysis, high level of fasting blood glucose may increase the risk of adverse discharge outcomes after intravenous thrombolysis.

Key words: Ischemic stroke; Intravenous thrombolysis; Fasting blood glucose; Functional outcome

摘要： 目的探讨空腹血糖与接受静脉溶栓的缺血性卒中患者功能结局的关系。
方法回顾性收集2018年10月—2020年11月首都医科大学附属北京天坛医院静脉溶栓患者的病历资料。纳入发病4.5 h内接受阿替普酶静脉溶栓的缺血性卒中患者为研究对象，采集相关研究数据（包括空腹血糖等）。研究结局设定为出院时功能结局良好，即mRS评分0～1分。采用多因素logistic回归分析探讨空腹血糖与功能结局的关联性。
结果共入组205例患者，平均年龄为（63.21±11.67）岁，其中153例（74.63%）患者为男性，入院NIHSS评分为5（3～9）分。其中117例（57.07%）患者出院时功能结局不良，88例（42.93%）患者出院时功能结局良好。功能结局良好的患者空腹血糖水平低于功能结局不良的患者[5.10（4.46～7.06）mmol/L
vs. 6.33（5.09～7.79）mmol/L，P=0.001]。多因素logistic回归分析结果显示，校正年龄、性别、NIHSS评分后，空腹血糖水平与接受静脉溶栓功能结局相关（OR 0.876，95%CI 0.774～0.991，P=0.035）；校正年龄、性别、NIHSS评分、桥接取栓后，关联性没有达到统计学意义（OR 0.891，95%CI 0.791～1.004，P=0.058）。
结论对于接受静脉溶栓的缺血性卒中患者，高水平空腹血糖可能会增加静脉溶栓后出院功能结局不良风险。

关键词: 缺血性卒中; 静脉溶栓; 空腹血糖; 功能预后

CLC Number:

DING Zeyu, LI Guangshuo, ZHAO Xingquan. Relationship between High Levels of Fasting Blood Glucose and Functional Outcome after Intravenous Thrombolysis in Patients with Ischemic Stroke[J]. Chinese Journal of Stroke, 2024, 19(3): 293-298.

丁则昱, 李光硕, 赵性泉. 高水平空腹血糖与缺血性卒中患者静脉溶栓后功能结局的关系分析[J]. 中国卒中杂志, 2024, 19(3): 293-298.

References

[1] POWERS W J，DERDEYN C P，BILLER J，et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment：a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke，2015，46（10）：3020-3035.
[2] POWERS W J，RABINSTEIN A A，ACKERSON T，et al. Guidelines for the early management of patients with acute ischemic stroke：2019 update to the 2018 guidelines for the early management of acute ischemic stroke：a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J/OL]. Stroke，2019，50（12）：e344-e418[2023-01-11]. https://doi.org/10.1161/STR.
0000000000000211.
[3] MA H，CAMPBELL B C V，PARSONS M W，et al. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke[J]. N Engl J Med，2019，380（19）：1795-1803.
[4] AY H，KOROSHETZ W J，VANGEL M，et al. Conversion of ischemic brain tissue into infarction increases with age[J]. Stroke，2005，36（12）：2632-2636.
[5] REGENHARDT R W，DAS A S，STAPLETON C J，et al. Blood pressure and penumbral sustenance in stroke from large vessel occlusion[J/OL]. Front Neurol，2017，8：317[2023-01-11]. https://doi.org/10.3389/fneur.2017.00317.
[6] BAIRD T A，PARSONS M W，PHAN T，et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome[J]. Stroke，2003，34（9）：2208-2214.
[7] RINKEL L A，NGUYEN T T M，GUGLIELMI V，et al. High admission glucose is associated with poor outcome after endovascular treatment for ischemic stroke[J]. Stroke，2020，51（11）：3215-3223.
[8] DESILLES J P，MESEGUER E，LABREUCHE J，et al. Diabetes mellitus，admission glucose，and outcomes after stroke thrombolysis：a registry and systematic review[J]. Stroke，2013，44（7）：1915-1923.
[9] JOHNSTON K C，BRUNO A，PAULS Q，et al. Intensive vs. standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke：the SHINE randomized clinical trial[J]. JAMA，2019，322（17）：326-335.
[10] CAO W J，LING Y F，WU F，et al. Higher fasting glucose next day after intravenous thrombolysis is independently associated with poor outcome in acute ischemic stroke[J]. J Stroke Cerebrovasc Dis，2015，24（1）：100-103.
[11] OSEI E，FONVILLE S，ZANDBERGEN A A M，et al. Impaired fasting glucose is associated with unfavorable outcome in ischemic stroke patients treated with intravenous alteplase[J]. J Neurol，2018，265（6）：1426-1431.
[12] LYDEN P，BROTT T，TILLEY B，et al. Improved reliability of the NIH stroke scale using video training. NINDS TPA stroke study group[J]. Stroke，1994，25（11）：2220-2226.
[13] ADAMS HP，Jr，BENDIXEN B H，KAPPELLE L J，et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10 172 in acute stroke treatment[J]. Stroke，1993，24（1）：35-41.
[14] HACKE W，KASTE M，BLUHMKI E，et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke[J]. N Engl J Med，2008，359（13）：1317-1329.
[15] HUYBRECHTS K F，CARO J J，XENAKIS J J，et al. The prognostic value of the modified Rankin scale score for long-term survival after first-ever stroke. Results from the Athens stroke registry[J]. Cerebrovasc Dis，2008，26（4）：381-387.
[16] HAFEZ S，COUCHA M，BRUNO A，et al. Hyperglycemia，acute ischemic stroke，and thrombolytic therapy[J]. Transl Stroke Res，2014，5（4）：442-453.
[17] CHEN G，REN J，HUANG H，et al. Admission random blood glucose，fasting blood glucose，stress hyperglycemia ratio，and functional outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis[J/OL]. Front Aging Neurosci，2022，14：782282[2023-01-11]. https://doi.org/10.3389/fnagi.2022.782282.
[18] DUNGAN K M，BRAITHWAITE S S，PREISER J C. Stress hyperglycaemia[J]. Lancet. 2009，373（9677）：1798-1807.
[19] LUITSE M J，BIESSELS G J，RUTTEN G E，et al. Diabetes，hyperglycaemia，and acute ischaemic stroke[J]. Lancet Neurol，2012，11（3）：261-271.
[20] KORACEVIC G P. Proposal of a new approach to study and categorize stress hyperglycemia in acute myocardial infarction[J]. J Emerg Med，2016，51（1）：31-36.
[21] DIETRICH W D，ALONSO O，BUSTO R. Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats[J]. Stroke，1993，24（1）：111-116.